Erratum: Retraction statement (Digestive Diseases (2012) 30 (196-200) DOI: 10.1159/000336965);Gut microbiota and obesity

Digestive Diseases

Volumn 30, Issue 2, 2012, Pages 196-200

  Krznarić, Željko ^a   Vranešić Bender, Darija ^a   Kunović, Ana ^a   Kekez, Domina ^a   Štimac, Davor ^b  

^a KBC Zagreb   (Croatia)

^b KBC RIJEKA   (Croatia)

Author keywords

Bacteroidetes; Firmicutes; Microbiota; Obesity; Prebiotics; Probiotics

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

ACTINOBACTERIA; ARTICLE; BACTERIAL STRAIN; BACTEROIDETES; ESCHERICHIA COLI; FIRMICUTES; HUMAN; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS CASEI; LACTOBACILLUS GASSERI; LACTOBACILLUS PARACA; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LIPID STORAGE; METABOLISM; NONHUMAN; OBESITY; PREVOTELLACEAE; PRIORITY JOURNAL; REGULATORY MECHANISM; WEIGHT REDUCTION;

EID: 84862894588     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000358548     Document Type: Erratum

References (40)

1. Neish AS: Microbes in gastrointestinal health and disease. Gastroenterology 2009; 136: 65-80.
2. Zoetendal EG, Vaughan EE, de Vos WM: A microbial world within us. Mol Microbiol 2006; 59: 1639-1650.
3. Andoh A, Benno Y, Kanauchi O, Fujiyama Y: Recent advances in molecular approaches to gut microbiota in inflammatory bowel disease. Curr Pharm Des 2009; 15: 2066-2073.
4. Backhed F, Ding H, Wang T, et al: The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101: 15718-15723.
5. Backhed F, Manchester JK, Semenkovich CF, et al: Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007; 104: 979-984.
6. Ley RE, Backhed F, Turnbaugh P, et al: Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005; 102: 11070-11075.
7. Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI: Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008; 3: 213-223.
8. Turnbaugh PJ, Ridaura VK, Faith JJ, et al: The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009; 1: 1-10.
9. Turnbaugh PJ, Ley RE, Mahowald MA, et al: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031.
10. Ley RE, Turnbaugh PJ, Klein S, et al: Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-1023.
11. Zhang H, DiBaise JK, Zuccolo A, et al: Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 2009; 106: 2365-2370.
12. Turnbaugh PJ, Hamady M, Yatsunenko T, et al: A core gut microbiome in obese and lean twins. Nature 2009; 457: 480-484.
13. Schwiertz A, Taras D, Schäfer K, Beijer S, Bos NA, Donus C, Hardt PD: Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2010; 18: 190-195.
14. Duncan SH, Lobley GE, Holtrop G, Ince J, Johnstone AM, Louis P, Flint HJ: Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond) 2008; 32: 1720-1724.
15. Arumugam M, Raes J, Pelletier E, et al: Enterotypes of the human gut microbiome. Nature 2011; 473: 174-180.
16. Santacruz A, Marcos A, Wärnberg J, et al: Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity (Silver Spring) 2009; 17: 1906-1915.
17. Nadal I, Santacruz A, Marcos A, et al: Shifts in clostridia, bacteroides and immunoglobulin coating fecal bacteria associated with weight loss in obese adolescents. Int J Obes 2009; 33: 758-767.
18. Wu X, Ma C, Han L, et al: Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol 2010; 61: 69-78.
19. Larsen N, Vogensen FK, van den Berg FW, et al: Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010; 5:e9085.
20. Musso G, Gambino R, Cassader M: Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care 2010; 33: 2277-2284.
21. Jia W, Li H, Zhao L, Nicholson JK: Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov 2008; 7: 123-129.
22. Naito E, Yoshida Y, Makino K, et al: Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J Appl Microbiol 2011; 110: 650-657.
23. Lee HY, Park JH, Seok SH, et al: Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Biochim Biophys Acta 2006; 1761: 736-744.
24. Kang JH, Yun SI, Park HO: Effects of Lactobacillus gasseri BNR17 on body weight and adipose tissue mass in diet-induced overweight rats. J Microbiol 2010; 48: 712-714.
25. Sato M, Uzu K, Yoshida T, et al: Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. Br J Nutr 2008; 99: 1013-1017.
26. Takemura N, Okubo T, Sonoyama K: Lactobacillus plantarum strain No. 14 reduces adipocyte size in mice fed high-fat diet. Exp Biol Med (Maywood) 2010; 235: 849-856.
27. Aronsson L, Huang Y, Parini P, et al: Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS One 2010; 5:e13087.
28. Karlsson CL, Molin G, Fak F, et al: Effects on weight gain and gut microbiota in rats given bacterial supplements and a high-energydense diet from fetal life through to 6 months of age. Br J Nutr 2011; 106: 887-895.
29. Kadooka Y, Sato M, Imaizumi K, et al: Regulation of abdominal adiposity by probiotics ( Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 2010; 64: 636-643.
30. Andreasen AS, Larsen N, Pedersen-Skovsgaard T, et al: Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr 2010; 104: 1831-1838.
31. Rastmanesh R: High polyphenol, low probiotic diet for weight loss because of intestinal microbiota interaction. Chem Biol Interact 2011; 189: 1-8.
32. Delzenne NM, Cani PD: Nutritional modulation of gut microbiota in the context of obesity and insulin resistance. Potential interest of prebiotics. Int Dairy J 2010; 20: 277-280.
33. Cani PD, Delzenne NM: The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009; 15: 1546-1558.
34. Neyrinck AM, Delzenne NM: Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders. Curr Opin Clin Nutr Metab Care 2010; 13: 722-728.
35. Abrams SA, Griffin IJ, Hawthorne KM, Ellis KJ: Effect of prebiotic supplementation and calcium intake on body mass index. J Pediatr 2007; 151: 293-298.
36. Genta S, Cabrera W, Habib N, Pons J, Carillo IM, Grau A, Sanchez S: Yacon syrup: beneficial effects on obesity and insulin resistance in humans. Clin Nutr 2009; 28: 182-187.
37. Parnell JA, Reimer RA: Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 2009; 89: 1751-1759.
38. Cani PD, Lecourt E, Dewulf EM, Sohet FM, Pachikian BD, Naslain D, De BF, Neyrinck AM, Delzenne NM: Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 2009; 90: 1236-1243.
39. Mahowald MA, Rey FE, Seedorf H: Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci USA 2009; 106: 5859-5864.
40. Delzenne NM, Neyrinck AM, Cani PD: Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact 2011; 10(suppl 1):S10.